Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression

Brain, Behavior, and Immunity

Volumn 22, Issue 5, 2008, Pages 781-792

  Temoshok, Lydia R ^a   Waldstein, Shari R ^a,b,c   Wald, Rebecca L ^a   Garzino Demo, Alfredo ^a,d   Synowski, Stephen J ^a   Sun, Lingling ^a   Wiley, James A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Chemokines; Alexithymia; Cardiovascular reactivity; HIV progression; Interleukin 6; MIP 1 alpha; Psychoneuroimmunology; Type C coping

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADULT; AGE DISTRIBUTION; ALEXITHYMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COPING BEHAVIOR; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HEART RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERSONALITY DISORDER; PRIORITY JOURNAL; STRESS; TYPE C COPING; VIRUS REPLICATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFFECTIVE SYMPTOMS; CARDIOVASCULAR SYSTEM; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CCL4; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART RATE; HIV INFECTIONS; HUMANS; IMMUNITY; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; MALE; MIDDLE AGED; PSYCHONEUROIMMUNOLOGY; RECOVERY OF FUNCTION; STRESS, PSYCHOLOGICAL;

EID: 44749084721     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.02.003     Document Type: Article

References (94)

1. Ashton E., Vosvick M., Chesney M., Gore-Felton C., Koopman C., O'Shea K., Maldonado J., Bachmann M.H., Israelski D., Flamm J., and Spiegel D. Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS. AIDS Patient Care STDS 19 (2005) 587-598
2. Bachen E.A., Manuck S.B., Cohen S., Muldoon M.F., Raible R., Herbert T.B., and Rabin B. Adrenergic blockade ameliorates cellular immune responses to mental stress in humans. Psychosom. Med. 57 (1995) 366-372
3. Bagby R.M., Parker J.D.A., and Taylor G.J. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross validation of the factor structure. J. Psychosom. Res. 38 (1994) 23-32
4. Bagby R.M., Taylor G.J., and Atkinson L. Alexithymia: a comparative study of three self-report measures. J. Psychosom. Res. 32 (1988) 107-116
5. Balbin E.G., Ironson G.H., and Solomon G.F. Stress and coping: the psychoneuroimmunology of HIV/AIDS. Bailliere Clin. Endocrin. 13 (1999) 615-633
6. Benschop R.J., Jacobs R., Sommer B., Scharmeyer T.H., Raab J.R., Schmidt R.E., and Schedlowski M. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB 10 (1996) 517-524
7. Birx D.L., Redfield R.R., Tencer K., Fowler A., Burke D.S., and Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76 (1990) 2303-2310
8. Branson B. Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. J. Med. Virol. 79 (2007) S6-S10
9. Breen E.C., Rezai A.R., Nakajima K., Beall G.N., Mitsuyasu R.T., Hirano T., Kishimoto T., and Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144 (1990) 480-484
10. Brownley, K.A., Hurwitz, B.E. 2003. Assessment of autonomic and cardiovascular function in HIV disease. In: Barbaro, G. (Ed.), HIV Infection and the Cardiovascular System. Adv. Cardiol. 40, 105-139.
11. Brownley K.A., Milanovich J.R., Motivala S.J., Schneiderman N., Fillion L., Graves J.A., Klimas N.G., Fletcher M.A., and Hurwitz B.E. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin. Auton. Res. 11 (2001) 319-326
12. Butler E.A., Egloff B., Wilhelm F.W., Smith N.C., Erickson E.A., and Gross J.J. The social consequences of expressive suppression. Emotion 3 (2003) 48-67
13. Cacioppo J.T., Berntson G.G., Larsen J.T., Poehlmann K.M., and Ito T.A. The psychophysiology of emotion. In: Lewis M., and Haviland-Jones J.M. (Eds). Handbook of Emotions (2000), Guilford Press, New York 173-191
14. Cacioppo J.T., Kiecolt-Glaser J.K., Malarkey W.B., Laskowski B.F., Roziog L.A., Poehlmann K.M., Burleson M.H., and Glaser R. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr Virus. Horm. Behav. 42 (2002) 32-41
15. Cacioppo J.T., Malarkey W.B., Kiecolt-Glaser J.K., Uchino B.N., Sgoutas-Emch S.A., Sheridan J.F., Berntson G.G., and Glaser R. Heterogeneity in neuroendocrine and immune responses to brief psychological stressors as a function of autonomic cardiac activation. Psychosom. Med. 57 (1995) 154-164
16. Carrico, A.W., Antoni, M.H., Young, L., Gorman, J.M., in press. Psychoneuroimmunology and HIV. Oxford University Press, Oxford.
17. Clerici M., Trabattoni D., Piconi S., Fusi M.L., Ruzzante S., Clerici C., and Villa M.L. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology 22 (1997) S27-S31
18. + cells. Science 270 (1995) 1811-1815
19. + T cells are associated with asymptomatic HIV-1 infection. Proc. Natl. Acad. Sci. USA 97 (2000) 13812-13817
20. Cole S., Korin Y., Fahey J., and Zack J. Norepinephrine accelerates HIV replication via protein kinase A-dependant effects on cytokine production. J. Immunol. 161 (1998) 610-616
21. Cole S., Naliboff B., Kemeny M., Griswold M., Fahey J., and Zack J. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc. Nat. Acad. Sci. USA 98 (2001) 12695-12700
22. Cole S.W., Kemeny M.E., Fahey J.L., Zack J.A., and Naliboff B.D. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol. Psychiatry 54 (2003) 1444-1456
23. Collaborative Group on AIDS Incubation and HIV Survival, 2000. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 355, 1131-1137.
24. Decrion A.Z., DiChamp I., Varin A., and Herbein G. HIV and inflammation. Curr. HIV Res. 3 (2005) 243-259
25. Ekman P., Levenson R.W., and Friesen W.V. Autonomic nervous system activity distinguishes among emotions. Science 221 (1983) 1208-1210
26. Garssen B., and Remie M. Different concepts or different words?. In: Nyklíček I., Temoshok L., and Vingerhoets A. (Eds). Emotional Expression and Health (2004), Brunner-Routledge, Hove and New York
27. Garzino-Demo A. Chemokines and defensins as HIV suppressive factors: an evolving story. Curr. Pharm. Des. 13 (2007) 163-172
28. Garzino-Demo A., Moss R.B., Margolick J.B., Cleghorn F., Sill A., Blattner W.A., Cocchi F., Carlo D.J., DeVico A.L., and Gallo R.C. Spontaneous and antigen-induced production of HIV-inhibitory b-chemokines are associated with AIDS-free status. Proc. Natl. Acad. Sci. USA 96 (1999) 11986-11991
29. Glaser R., and Kiecolt-Glaser J.K. Stress-associated immune modulation and its implications for reactivation of ltent herpes-viruses. In: Glaser R., and Jones J. (Eds). Human Herpesvirus Infections (1994), Marcel Dekker, New York 245-270
30. Glaser R., Litsky M.L., Padgett D.A., Baiocchi R.A., Yang E.V., Chen M., Yeh P.-E., Green-Church K.B., Caligiuri M.A., and Williams M.V. EBV-encoded dUTPase induces immune dysregulation: implications for the pathophysiology of EBV-associated disease. Virology 346 (2006) 205-218
31. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R.J., Freedman B.I., Quinones M.P., Bamshad M.J., Murthy K.K., Rovin B.H., Bradley W., Clark R.A., Anderson S.A., O'Connell R.J., Agan B.K., Ahuja S.S., Bologna R., Sen L., Dolan M.J., and Ahuja S.K. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307 (2005) 1434-1440
32. Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., and Szabo C. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br. J. Pharmacol. 125 (1998) 1297-1303
33. Honda M., Kitamura K., Mizutani Y., Oishi M., Arai M., Okura T., Igarahi K., Yasukawa K., Hirano T., and Kishimoto T. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J. Immunol. 145 (1990) 4059-4064
34. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav. Immun. 16 (2002) 1-16
35. Johnson J.D., O'Connor K.A., Deak T., Stark M., Watkins L.R., and Maier S.F. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 16 (2002) 461-476
36. Kamarck T.W., Jennings J.R., Debski T.T., Glickman-Weiss E., Johnson P.S., Eddy M.J., and Manuck S.B. Reliable measures of behaviorally-evoked cardiovascular reactivity from a PC-based test battery: results from student and community samples. Psychophysiology 29 (1992) 17-28
37. Kiecolt-Glaser J.K., Loving T.J., Stowell J.R., Malarkey W.B., Lemeshow S., Dicinson S.L., and Glaser R. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch. Gen. Psychiatry 62 (2005) 1377-1384
38. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., and Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100 (2003) 9090-9095
39. Kinter A., Arthos J., Cicala C., and Fauci A.S. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol. Rev. 177 (2000) 88-98
40. Kopinsky K.L., Stoff D.M., and Rausch D.M. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav. Immun. 18 (2004) 246-261
41. Lafeuillade A., Poizot-Martin I., Quilichini R., Gastaut J.A., Kaplanski S., Farnarier C., Mege J.L., and Bongrand P. Increased interleukin-6 production is associated with disease progression in HIV infection. AIDS 5 (1991) 1139-1140
42. Lawn S.D., Butera S.T., and Folks T.M. Contribution of immune activation to the pathogenesis and progression of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14 (2001) 753-777
43. Lederman M.M., McKinnis R., Kelleher D., Cutrell A., Mellors J., Neisler M., Cooney E., Haas D.W., Haubrich R., Stanford J., Horton J., Landay A., and Spreen W. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS 14 (2000) 2635-2642
44. Leserman, J., in press. The role of depression, stress and trauma in HIV disease progression. Psychosom. Med.
45. Linden W., Wen F., and Paulhus D.L. Measuring alexithymia: reliability, validity, and prevalence. Adv. Personal. Assess. 10 (1995) 55-95
46. Lumley M.A., Tomakowsky J., and Torosian T. The relationship of alexithymia to subjective and biomedical measures of disease. Psychosomatics 38 (1997) 497-502
47. Lumley M.A., Stettner L., and Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J. Psychosom. Res. 41 (1996) 505-518
48. Mackay C.R. CCL3L1 dose and HIV-1 susceptibility. Trends Mol. Med. 11 5 (2005) 203-206
49. Manuck S., Cohen S., Rabin B., Muldoon M., and Bachen E. Individual differences in cellular immune responses to stress. Psychol. Sci. 2 (1991) 111-115
50. Mauss I.B., Levenson R.W., McCarter L., Wilhelm F.H., and Gross J.J. The tie that binds? Coherence among emotion experience, behavior, and physiology. Emotion 5 (2005) 175-190
51. McCaul M.E., Bigelow G.E., Stitzer M.L., and Liebson I. Short-term effects of oral methadone in methadone maintenance subjects. Clin. Pharmacol. Ther. 31 (1982) 753-761
52. McEwen B.S., and Stellar E. Stress and the individual: mechanisms leading to disease. Arch. Intern. Med. 153 (1993) 2093-2101
53. Miller V., Mocroft A., Reiss P., Katlama C., Papadopoulos A.I., Katzenstein T., van Lunzen J., Antunes F., Phillips A.N., and Lundgren J.D. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann. Intern. Med. 130 (1999) 570-577
54. Nakajima K., Martinez-Maza O., Hirano T., Breen E.C., Nishanian P.G., Salazar-Gonzalez J.F., Fahey J.L., and Kishimoto T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J. Immunol. 142 (1989) 531-536
55. Neumann S.A., Sollers J.J., Thayer J.F., and Waldstein S.R. Alexithymia predicts attenuated autonomic reactivity, but prolonged recovery to anger recall in young women. Int. J. Psychophysiol. 53 (2004) 183-195
56. + lymphocyte counts and the risk of progression to AIDS. New Engl. J. Med. 334 (1996) 426-431
57. O'Cleirigh C., Ironson G., Antoni M., Fletcher M.A., McGuffey L., Balbin E., Schneiderman N., and Solomon G. Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J. Psychosom. Res. 54 (2003) 225-235
58. Perrella O., Guerriero M., Izzo E., Soscia M., and Carrieri P.B. Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arq. Neuropsiquiatr. 50 (1992) 180-182
59. Pezzotti P., Phillips A.N., Dorrucci M., Lepri A.C., Galai N., Vlahov D., and Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. B. M. J. 313 (1996) 583-586
60. Poli G., Bressler P., Kinter A., Duh E., Timmer W.C., Rabson A., Justement J.S., Stanley S., and Fauci A.S. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172 (1990) 151-158
61. Richards J.M., and Gross J.J. Composure at any cost? The cognitive consequences of emotion suppression. Per. Soc. Psychol. Bull. 25 (1999) 1033-1044
62. Roberts E.S., Burudi E.M., Flynn C., Madden L.J., Roinick K.L., Watry D.D., Zandonatti M.A., Taffe M.A., and Fox H.S. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J. Neuroimmunol. 157 (2004) 81-92
63. Robles T.F., Glaser R., and Kiecolt-Glaser J.K. Out of Balance: a new look at chronic stress, depression, and immunity. Curr. Dir. Psychol. Sci. 14 (2005) 111-115
64. Sgoutas-Emch S.A., Cacioppo J.T., Uchino B.N., Malarkey W., Pearl D., Kiecolt-Glaser J.K., and Glaser R. The effects of an acute psychological stressor on cardiovascular, endocrine, and cellular immune response: a prospective study of individuals high and low in heart rate reactivity. Psychophysiology 31 (1994) 264-271
65. Sloan E.K., Collado-Hidalgo A., and Cole S. Psychobiology of HIV infection. In: Ader R. (Ed). Psychoneuroimmunology. Fourth Edition vol. 2 (2007), Elsevier Academic Press, Burlington, MA
66. Solano L., Costa M., Salvati S., Coda R., Aiuti F., Mezzaroma I., and Bertini M. Psychosocial factors and clinical evolution in HIV-infection: a longitudinal study. J. Psychosom. Res. 37 (1993) 39-51
67. Solano L., Costa M., Temoshok L., Salvati S., Coda R., Aiuti F., Di Sora F., D'Offizi G., Figa-Talamanca L., Mezzaroma I., Montella F., and Bertini M. An emotionally inexpressive (Type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychol. Health 7 (2002) 641-655
68. Solomon G.F., Kemeny M., and Temoshok L. Psychoneuroimmunologic aspects of Human Immunodeficiency Virus infection. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology II (1991), Academic Press, Orlando, FL 1081-1113
69. Solomon G.F., and Temoshok L. A psychoneuroimmunologic perspective on AIDS research: Questions, preliminary findings, and suggestions. J. Appl. Soc. Psychol. 17 (1987) 286-308
70. Sun L., Abdelwahab S.F., Lewis G.K., and Garzino-Demo A. Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization. Int. Immunol. 16 11 (2004) 1623-1631
71. Taylor G.J., Bagby R.M., and Parker J.D.A. Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness (2001), Cambridge University Press, Cambridge
72. Taylor G.J. Alexithymia: 25 years of theory and research. In: Nyklíček I., Temoshok L., and Vingerhoets A. (Eds). Emotional Expression and Health (2004), Brunner-Routledge, Hove and New York
73. Taylor G.J., Bagby R.M., Ryan D.P., Parker J.D.A., Doody K.F., and Keefe P. Criterion validity of the Toronto Alexithymia Scale. Psychosom. Med. 50 (1988) 500-509
74. Temoshok L. Emotion, adaptation, and disease. In: Temoshok L., Van Dyke C., and Zegans L.S. (Eds). Emotions in Health and Illness: Theoretical and Research Foundations (1983), Grune and Stratton, New York
75. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response. Soc. Sci. Med. 20 (1985) 833-840
76. Temoshok L. Personality, coping style, emotion, and cancer: toward an integrative model. Cancer Surv. 6 (1987) 837-857
77. Temoshok L. On attempting to articulate the biopsychosocial model: psychological-psychophysiological homeostasis. In: Friedman H. (Ed). Personality and Disease (1990), John Wiley and Sons, New York 203-225
78. Temoshok L. Complex coping patterns and their role in adaptation and neuroimmunomodulation: theory, methodology, and research. Ann. NY Acad. Sci. 917 (2000) 446-455
79. Temoshok L. Psychological response and survival in breast cancer. Lancet 355 (2000) 404-405
80. Temoshok L.R. Connecting the dots linking mind, behavior, and disease: the biological concomitants of coping patterns. Integr. Cancer Ther. 1 (2002) 387-391
81. Temoshok L.R. Type C coping and cancer progression. In: Fernandez-Ballesteros R. (Ed). The Encyclopedia of Psychological Assessment vol. 2 (2003), Sage, New York 1052-1056
82. Temoshok L.R. Type C coping/behavior pattern. In: Christensen A.J., Martin R., and Smyth J.M. (Eds). Health Psychology (2004), Plenum, New York 332-333
83. Temoshok L., and Dreher H. The Type C Connection: The Behavioral Links to Cancer and Your Health (1992), Random House, New York
84. Temoshok, L., Heller, B.W. 1981. Stress and "Type C" versus epidemiological risk factors in melanoma. In: Proceedings of the 89th Annual Convention of the American Psychological Association. American Psychological Association, Washington, DC.
85. Temoshok L., Heller B.W., Sagebiel R.W., Blois M.S., Sweet D.M., DiClemente R.J., and Gold M.L. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J. Psychosom. Res. 29 (1985) 139-153
86. Temoshok, L.R., Wald, R.L., Synowski, S., Garzino-Demo, A., in press. Coping as a multi-system construct that may influence pathways mediating HIV-relevant immune function and disease progression. Psychosom. Med.
87. Temoshok, L., Zich, J., Solomon, G.F., Stites, D.P., 1987. An intensive psychoimmunologic study of long-surviving persons with AIDS. Procedings, The III International Conference on AIDS, Washington, DC.
88. Thayer J.F., and Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann. NY Acad. Sci. 1088 (2006) 361-372
89. Torre D., Zeroli C., Ferraro G., Speranza F., Tambini R., Martegani R., and Fiori G.P. Cerebrospinal fluid levels of IL-6 in patients with acute infections of the central nervous system. Scand. J. Infect. Dis. 24 (1992) 787-791
90. Ullum H., Cozzi A., Victor J., Aladdin A., Phillips A.N., Gerstoft J., Skinhej P., and Pedersen B.K. Production of beta-chemokines in human immunodeficiency virus (HIV-1) infection: evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J. Infect. Dis. 33 (1998) 331-336
91. Wald R.L., Dowling G.C., and Temoshok L.R. Coping styles predict immune system parameters and clinical outcomes in patients with HIV. Retrovirology 3 Suppl. 1 (2006) P65
92. Waldstein S.R., Kauhanen J., Neumann S.A., and Katzel L.I. Alexithymia and cardiovascular risk in older adults: psychosocial, psychophysiological, and biomedical correlates. Psychol. Health 17 (2002) 597-610
93. Waldstein S.R., Kop W.J., Schmidt L.A., Haufler A.J., Krantz D.S., and Fox N.A. Frontal electrocortical and cardiovascular reactivity during happiness and anger. Biol. Psychol. 55 (2000) 3-23
94. Waldstein S.R., Neumann S.A., Burns H.A., and Maier K.J. Role-played interpersonal interaction: ecological validity and cardiovascular reactivity. Ann. Behav. Med. 20 (1998) 302